Role of PET/CT in Peritoneal Deposits Assessment

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06137417

Enrollment

Registered

2023-11-18

Start date

2024-01-01

Completion date

2026-03-15

Last updated

2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal Metastases

Brief summary

• Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment of peritoneal deposits

Detailed description

Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment of peritoneal deposits. we will find its diagnostic role.

Interventions

DEVICEPET/CT

• Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* • Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions.

Exclusion criteria

* • Patients unable to sit calm without movement during imaging. * Severely ill patients. * Patients unable to sleep in a fixed position for 20 minutes. * Pregnancy

Design outcomes

Primary

Measure	Time frame	Description
role of pet/ct in peritoneal deposits assessment	2 years	Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment of peritoneal deposits

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026